Cargando…
(99m)Tc-labelled Stealth® liposomal doxorubicin (Caelyx®) in glioblastomas and metastatic brain tumours
British Journal of Cancer (2002) 86, 659–660. DOI: 10.1038/sj/bjc/6600093 www.bjcancer.com © 2002 Cancer Research UK
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2002
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375284/ https://www.ncbi.nlm.nih.gov/pubmed/11870553 http://dx.doi.org/10.1038/sj.bjc.6600093 |
| _version_ | 1782154620594814976 |
|---|---|
| author | Laverman, P Boerman, O C Storm, G Oyen, W J G |
| author_facet | Laverman, P Boerman, O C Storm, G Oyen, W J G |
| author_sort | Laverman, P |
| collection | PubMed |
| description | British Journal of Cancer (2002) 86, 659–660. DOI: 10.1038/sj/bjc/6600093 www.bjcancer.com © 2002 Cancer Research UK |
| format | Text |
| id | pubmed-2375284 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2002 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-23752842009-09-10 (99m)Tc-labelled Stealth® liposomal doxorubicin (Caelyx®) in glioblastomas and metastatic brain tumours Laverman, P Boerman, O C Storm, G Oyen, W J G Br J Cancer Letter to the Editor British Journal of Cancer (2002) 86, 659–660. DOI: 10.1038/sj/bjc/6600093 www.bjcancer.com © 2002 Cancer Research UK Nature Publishing Group 2002-02-12 /pmc/articles/PMC2375284/ /pubmed/11870553 http://dx.doi.org/10.1038/sj.bjc.6600093 Text en Copyright © 2002 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter to the Editor Laverman, P Boerman, O C Storm, G Oyen, W J G (99m)Tc-labelled Stealth® liposomal doxorubicin (Caelyx®) in glioblastomas and metastatic brain tumours |
| title | (99m)Tc-labelled Stealth® liposomal doxorubicin (Caelyx®) in glioblastomas and metastatic brain tumours |
| title_full | (99m)Tc-labelled Stealth® liposomal doxorubicin (Caelyx®) in glioblastomas and metastatic brain tumours |
| title_fullStr | (99m)Tc-labelled Stealth® liposomal doxorubicin (Caelyx®) in glioblastomas and metastatic brain tumours |
| title_full_unstemmed | (99m)Tc-labelled Stealth® liposomal doxorubicin (Caelyx®) in glioblastomas and metastatic brain tumours |
| title_short | (99m)Tc-labelled Stealth® liposomal doxorubicin (Caelyx®) in glioblastomas and metastatic brain tumours |
| title_sort | (99m)tc-labelled stealth® liposomal doxorubicin (caelyx®) in glioblastomas and metastatic brain tumours |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375284/ https://www.ncbi.nlm.nih.gov/pubmed/11870553 http://dx.doi.org/10.1038/sj.bjc.6600093 |
| work_keys_str_mv | AT lavermanp 99mtclabelledstealthliposomaldoxorubicincaelyxinglioblastomasandmetastaticbraintumours AT boermanoc 99mtclabelledstealthliposomaldoxorubicincaelyxinglioblastomasandmetastaticbraintumours AT stormg 99mtclabelledstealthliposomaldoxorubicincaelyxinglioblastomasandmetastaticbraintumours AT oyenwjg 99mtclabelledstealthliposomaldoxorubicincaelyxinglioblastomasandmetastaticbraintumours |